1. 2007
  2. Antibodies to HIV-1: aiming at the right target

    Eggink, D., Melchers, M. & Sanders, R. W., 2007, In: Trends in microbiology. 15, 7, p. 291-294

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells

    Shan, M., Klasse, P. J., Banerjee, K., dey, A. K., Iyer, S. P. N., Dionisio, R., Charles, D., Campbell-Gardener, L., Olson, W. C., Sanders, R. W. & Moore, J. P., 2007, In: PLoS pathogens. 3, 11, p. e169-1650

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 2006
  5. Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry

    Groot, F., Sanders, R. W., ter Brake, O., Nazmi, K., Veerman, E. C. I., Bolscher, J. G. M. & Berkhout, B., 2006, In: Journal of virology. 80, 18, p. 9236-9243

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2005
  7. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1

    Beddows, S., Schülke, N., Kirschner, M., Barnes, K., Franti, M., Michael, E., Ketas, T., Sanders, R. W., Maddon, P. J., Olson, W. C. & Moore, J. P., 2005, In: Journal of virology. 79, 14, p. 8812-8827

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction

    Groot, F., Geijtenbeek, T. B. H., Sanders, R. W., Baldwin, C. E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E. C. & Berkhout, B., 2005, In: Journal of virology. 79, 5, p. 3009-3015

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Protein promiscuity: drug resistance and native functions--HIV-1 case

    Fernández, A., Tawfik, D. S., Berkhout, B., Sanders, R., Kloczkowski, A., Sen, T. & Jernigan, B., 2005, In: Journal of biomolecular structure & dynamics. 22, 6, p. 615-624

    Research output: Contribution to journalEditorialAcademicpeer-review

  10. 2004
  11. Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor

    Baldwin, C. E., Sanders, R. W., Deng, Y., Jurriaans, S., Lange, J. M., Lu, M. & Berkhout, B., 2004, In: Journal of virology. 78, 22, p. 12428-12437

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Evolutionary repair of HIV type 1 gp41 with a kink in the N-terminal helix leads to restoration of the six-helix bundle structure

    Sanders, R. W., Busser, E., Moore, J. P., Lu, M. & Berkhout, B., 2004, In: AIDS research and human retroviruses. 20, 7, p. 742-749

    Research output: Contribution to journalArticleAcademicpeer-review

  13. Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41

    Sanders, R. W., Dankers, M. M., Busser, E., Caffrey, M., Moore, J. P. & Berkhout, B., 2004, In: Retrovirology. 1, 1, p. 3

    Research output: Contribution to journalArticleAcademicpeer-review

  14. The HIV-1 envelope glycoproteins: folding, function and vaccine design

    Sanders, R. W., 2004, 337 p.

    Research output: ThesisPhd-Thesis - Research and graduation internal

ID: 82305